October 2, 2022

Best Health Ideas

Every Health & Fitness Helps

Pfizer recalls 3 types of blood pressure medicine

NEW YORK (WFXR) — Pfizer issued a nationwide blood pressure recall because the presence of nitrosamine is above the Acceptable Daily Intake (ADI) level.

The recall is for Accuretic tablets and two generics distributed by Greenstone — quinapril and hydrochlorothiazide and quinapril HCI/hydrochlorothiazide.

Pfizer will pull six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets, and four lots of quinapril HCI/hydrochlorothiazide tablets.

Health officials say you can find nitrosamines in water and foods, cured and grilled meats, dairy products, and vegetables. However, people exposed to the above ADI levels of nitrosamines for a long period of time can increase the risk of cancer.

These products are used to help treat hypertension and lower blood pressure in people to decreases the risk of deadly and non-deadly cardiovascular events, strokes, and myocardial infarctions. Pfizer recommends patients who take this medication should talk to their doctors about alternative treatment options.

The recalled products are from November 2019 to March 2022 and were distributed throughout the United States and Puerto Rico. Below are the products on the recall list.

Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, Quinapril and hydrochlorothiazide tablets, and quinapril HCl/hydrochlorothiazide tablets recalled from Pfizer (Photos courtesy: Pfizer)
  • Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 10/12.5 mg
  • Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/12.5 mg
  • Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/25 mg
NDC Lot Number Expiration Date Strength Configuration/Count
0071-3112-23 FG5379 08/2024 10/12.5 mg 1 x 90 count bottle
0071-0222-23 EA6686 04/2022 10/12.5 mg 1 x 90 count bottle
0071-5212-23 FG5381 08/2024 20/12.5 mg 1 x 90 count bottle
0071-0220-23 EA6665 04/2022 20/12.5 mg 1 x 90 count bottle
0071-0220-23 CN0640 04/2022 20/12.5 mg 1 x 90 count bottle
0071-0223-23 ET6974 02/2023 20/25 mg 1 x 90 count bottle
Data from Pfizer
  • quinapril and hydrochlorothiazide tablets, 20/25 mg
  • quinapril HCl/hydrochlorothiazide tablets, 20/12.5 mg
  • quinapril HCl/hydrochlorothiazide tablets, 20/25 mg
NDC Lot Number Expiration Date Strength Configuration/Count
59762-5225-9 FE3714 02/2023 20/25 mg 1 x 90 count bottle
59762-0220-1 DN6931 03/2023 20/12.5 mg 1 x 90 count bottle
59762-0220-1 ED3904 03/2023 20/12.5 mg 1 x 90 count bottle
59762-0220-1 ED3905 03/2023 20/12.5 mg 1 x 90 count bottle
59762-0223-1 DP3414 02/2023 20/25 mg 1 x 90 count bottle
Data from Pfizer

Pfizer stated that wholesalers and distributors with any of these products should stop use and distribution and immediately quarantine the product.

For more information about this recall head to the Pfizer website here.